OAK STREET ADVISORS
  • HOME
  • SERVICES
    • Financial Planning
    • Tax Planning
    • Fiduciary Investment Management
    • Small Business Planning >
      • Business Retirement Plan Advisory
  • ABOUT US
    • WHAT IS A FEE ONLY ADVISOR?
    • FREQUENTLY ASKED QUESTIONS
    • OUR TEAM
  • BLOG
    • BLOG
  • SCHEDULE AN INTRO CALL
  • CONTACT A FINANCIAL PLANNER
  • Form ADV Part 2

News You Can Use

Why that $3 Billion Figure for Wasted Cancer Drugs is Wrong

3/9/2016

 
Picture
There is a story making its way around the internet about the supposed waste of high tech cancer drugs each year. A new study published Monday by a research team at New York’s Sloan Kettering Cancer Center, estimates the drugs left over after patients receive a cancer treatment to be worth $3 Billion

The problem with the study is the researchers do not understand the economics of drug pricing.  The drug manufacturer doesn't charge by the ounce, they charge by the treatment.

If drugs had permanence and were transferable, like say gold, they would be priced by some measure of unit size. But the drug manufacturer knows that once a treatment is given, the rest is discarded. Hence they price the drug for a treatment and provide enough medication for one treatment regardless of how much is in the vial.  The price for many drugs is not a function of manufacturing costs, it is a function of what the market will bear.  It may only cost $2.00 per ounce to produce a drug that can be sold for $1,000 per treatment, so if an ounce or two is thrown out now and then, not much economic input is lost.  It may even cost the drug manufacturer more to dispense the drug in varying quantities to meet the needs of different individuals.

To know how much is wasted each year you would need to use manufacturing costs, not retail prices.  You can be sure that that number is considerably less than $3 Billion and it would probably make us all sick if we really knew how much less it is.


Comments are closed.

    Archives

    November 2022
    September 2022
    November 2021
    September 2021
    July 2021
    June 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    July 2020
    June 2020
    March 2020
    February 2020
    January 2020
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    September 2017
    June 2017
    May 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    September 2015
    August 2015
    June 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014

    Categories

    All
    401k
    403b
    529 Plans
    Annuities
    Behavioral Economics
    Bonds
    Budget
    Charity
    College Planning
    Credit
    Credit Cards
    Crypto Currency
    Debt
    Economics
    Estate Planning
    Federal Reserve
    Fiduciary
    Financial Planning
    Goals
    Gold
    HSA
    Income Tax
    Income Tax Planning
    Insurance
    Interest Rates
    Investing
    Investments Expenses
    IRA
    Jobs
    Life Insurance
    Real Estate
    Retirement
    Retirement Income
    Risk
    Rollover
    Roth IRA
    Savings
    Social Security
    Special Needs
    Stocks

    RSS Feed

  • HOME
  • SERVICES
    • Financial Planning
    • Tax Planning
    • Fiduciary Investment Management
    • Small Business Planning >
      • Business Retirement Plan Advisory
  • ABOUT US
    • WHAT IS A FEE ONLY ADVISOR?
    • FREQUENTLY ASKED QUESTIONS
    • OUR TEAM
  • BLOG
    • BLOG
  • SCHEDULE AN INTRO CALL
  • CONTACT A FINANCIAL PLANNER
  • Form ADV Part 2